Stock Splits
By The Online Investor Staff, updated Mon., Jul. 22, 7:46 AM
| This Slide: #1 of 25 |
Slide #1. Neuralstem, Inc. (NASDAQ:CUR) — 1 for 20 Reverse Split
Announced:
7/16/2019
Stock Split:
1 for 20
Record Date:
7/16/2019
Pay Date:
7/17/2019
CUR Optionable?:
Yes
Neuralstem is a biopharmaceutical company. Co. is focused on the research and development of nervous system therapies based on its proprietary human neural stem cells and its small molecule compounds. Co.'s technology platform has produced two main assets in clinical development: NSI-189 a small molecule compound, for the prevention and treatment of diabetic neuropathy and NSI-566 stem cell for treatment of paralysis due to Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease), stroke, and spinal cord injury. All of Co.'s research efforts are at the pre-clinical or clinical stage of development. 
CUR Detailed Information Page & Split History »
|
|||||||||||||||||||||
Open the CUR Page at The Online Investor (in a new window) »
List of Stock Splits in this Slideshow: Ticker Stock Split Announced Record Date Pay Date Optionable VLRX 1 for 20 5/17/2019 5/17/2019 5/20/2019 No ONCS 1 for 10 5/20/2019 5/20/2019 5/21/2019 No MIDZ 1 for 5 5/24/2019 6/27/2019 6/28/2019 Yes TZA 1 for 5 5/24/2019 6/27/2019 6/28/2019 Yes FAZ 1 for 5 5/24/2019 6/27/2019 6/28/2019 Yes DRIP 1 for 5 5/24/2019 6/27/2019 6/28/2019 Yes GASL 1 for 5 5/24/2019 6/27/2019 6/28/2019 Yes JNUG 1 for 5 5/24/2019 6/27/2019 6/28/2019 Yes DRV 1 for 5 5/24/2019 6/27/2019 6/28/2019 Yes SOXS 1 for 10 5/24/2019 6/27/2019 6/28/2019 Yes SDLP 1 for 10 5/30/2019 7/1/2019 7/2/2019 Yes CTRV 1 for 70 5/31/2019 5/31/2019 6/3/2019 No HEB 1 for 44 5/31/2019 6/10/2019 6/11/2019 No DRAD 1 for 10 5/31/2019 6/4/2019 6/5/2019 Yes NTIC 2 for 1 6/3/2019 6/17/2019 6/28/2019 No KOOL 1 for 10 6/4/2019 6/4/2019 6/5/2019 No JAGX 1 for 70 6/6/2019 6/6/2019 6/7/2019 No HSON 1 for 10 6/10/2019 6/10/2019 6/11/2019 No SOMA 1 for 9 6/19/2019 6/19/2019 6/20/2019 No AVGR 1 for 10 6/21/2019 6/21/2019 6/24/2019 No YUMA 1 for 15 6/21/2019 7/2/2019 7/3/2019 No XBIO 1 for 12 6/24/2019 6/24/2019 6/25/2019 No CGA 1 for 12 6/28/2019 6/27/2019 6/28/2019 Yes FRAN 1 for 12 6/28/2019 7/1/2019 7/2/2019 Yes CUR 1 for 20 7/16/2019 7/16/2019 7/17/2019 Yes
|
|
Avg. Broker Rec.
|
Strong Buy (4.00 out of 4) 94th percentile
(ranked higher than approx. 94% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
